4 completed, 1 unknown. 3 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 2, Unknown 1 |
| Phase 1 | 2 | Completed 2 |
Follow Applied Molecular Transport: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SAD Study to Assess the Safety, Tolerability, PK, and In-Vivo Performance of AMT-126 in Healthy Male and Female Subjects AMT-126, Placebo, Radioactive Tablet (Part 2 Only) - Healthy Volunteers | Phase 1 | Completed | Applied Molecular Transport | 50 | 2021-02-26 | 2022-07-27 |
| Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET) AMT-101 (oral), Placebo (oral), Humira (adalimumab) - Ulcerative Colitis | Phase 2 | Completed | Applied Molecular Transport | 51 | 2021-02-05 | 2022-09-14 |
| Study of the Safety and Efficacy of AMT-101 in Subjects With Pouchitis AMT-101 (oral)-Dose A, AMT-101 (oral)-Dose B - Pouchitis | Phase 2 | Completed | Applied Molecular Transport | 22 | 2021-02-05 | 2022-09-14 |
| Study of the Efficacy and Safety of AMT-101 in Subjects With Ulcerative Colitis (LOMBARD) AMT-101 (oral), Placebo (oral) - Ulcerative Colitis | Phase 2 | Unknown | Applied Molecular Transport | 105 | 2020-08-26 | 2022-11-07 |
| SAD/MAD Study in Healthy Subjects and Adults With UC to Evaluate Safety, Tolerability, PK, PD of AMT-101 AMT-101, Placebos - Ulcerative Colitis | Phase 1 | Completed | Applied Molecular Transport | 52 | 2019-04-01 | 2020-10-28 |
Colitis, Ulcerative (3) · Inflammatory Bowel Diseases (3) · Pouchitis (1)
Adalimumab (1) · Radioactivity (1)
Georgia (3) · Germany (3) · Ukraine (3) · United Kingdom (3) · Canada (2) · France (2) · Hungary (2) · Moldova (2) · Netherlands (2) · Poland (2) · Switzerland (2) · United States (2) · Belarus (1) · Belgium (1) · Bulgaria (1)